Li Kang Biomedical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2019
May 07, 2019 at 06:49 pm
Share
Li Kang Biomedical Co., Ltd. announced earnings results for the first quarter ended March 31, 2019. For the first quarter, the company announced total revenue was TWD 115.754 million compared to TWD 105.496 million a year ago. Operating income was TWD 21.468 million compared to TWD 18.163 million a year ago. Net income was TWD 17.460 million compared to TWD 19.676 million a year ago. Basic earnings per share was TWD 0.79 compared to TWD 0.89 a year ago. Diluted earnings per share was TWD 0.78 compared to TWD 0.88 a year ago.
Li Kang Biomedical Co., Ltd. formerly BAFO TECHNOLOGIES CORP., is engaged in the manufacture and sale of computer, communication and consumer (3C) product cables and circumscribed computer peripheral products, as well as communication products. The Company offers unshielded twisted pair (UTP) cables, monitor cables, small computer system interface (SCSI) cables, universal serial bus (USB) cables, wireless hopping/mesh access points, wireless modules, and wireless vehicle communication systems, among others. The Company distributes its products within the domestic market and to overseas markets, including Europe, the Americas and the rest of Asia.
LI KANG BIOMEDICAL CO., LTD. 
